|
|
|
|
|
|
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Safety and Efficacy of LX3305, a Sphingosine-1-Phosphate Lyase Inhibitor, for Treatment of Darier’s Disease or Hailey-Hailey Disease - DERM-101
100 项与 Dermecular Therapeutics, Inc. 相关的临床结果
0 项与 Dermecular Therapeutics, Inc. 相关的专利(医药)
100 项与 Dermecular Therapeutics, Inc. 相关的药物交易
100 项与 Dermecular Therapeutics, Inc. 相关的转化医学